RETRACTED: Cancer immunotherapy-induced posterior reversible encephalopathy syndrome in an ED

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the authors. The patient actually had urothelial cancer of the renal pelvis and not renal cel...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of emergency medicine 2017-04, Vol.35 (4), p.663.e1-663.e2
Main Authors: Win, Myint Aung, Thein, Kyaw Zin, Yeung, Sai-Ching Jim
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the authors. The patient actually had urothelial cancer of the renal pelvis and not renal cell carcinoma as had been reported. The authors did not report that the patient's PRES resolved with glucocorticoid treatment. The oncology team disagreed with the authors’ attribution of the metabolic acidosis to posterior reversible encephalopathy syndrome.
ISSN:0735-6757
1532-8171
DOI:10.1016/j.ajem.2016.10.069